May 11, 2011

Sanofi Pasteur Launches Pentaxim®, First 5-in-1 Combination Vaccine in China

New vaccine Pentaxim® reduces infant shots from twelve to four

 

Sanofi Pasteur Launches Pentaxim®, First 5-in-1 Combination Vaccine in China
New vaccine Pentaxim® reduces infant shots from twelve to four

Lyon, France – May 11, 2011 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY) launched today Pentaxim®, the first 5-in-1 combination vaccine in China to immunize against diphtheria, tetanus, pertussis, polio and Haemophilus influenzae type b. The debut of the first 5-in-1 combination vaccine was celebrated with over 200 Chinese and international experts and hailed as the beginning of a new era in the immunization field in China. In order to facilitate the adoption of the new combination vaccine for the benefit of consumers, the Chinese Preventive Medicine Association (CPMA) introduced a first-of-its-kind technical guideline for doctors at Points of Vaccination.